FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/21/2022
Back to search
Official data from USPTO
CELLSAFE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
03/21/2022
Classification
Registered
Trademark type
Combined
Nice classes
5, 10, 35
Filing date
07/20/2020
Registration date
09/14/2021
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/14/2021
Last transaction
09/14/2021
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
KR
Examiner
KON, ELISSA
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the design of an orange oval background shape containing four white leaves to the left of the stylized wording "CELLSAFE" in dark green.
Holders and representatives
Holders
CellSafe
Representatives
Dennis S. Prahl, Esq. Ladas & Parry LLP
Technical classification
Nice Classes
Class 5Class 10Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic agents for pharmaceutical use; chemical preparations for use in DNA for medical purposes; biological reagents for medical purposes; reagents for use in medical genetic testing; medical diagnostic test strips for blood analysisurine analysis; diagnostic test reagents for medical purposes for testing body fluids for microorganisms; diagnostic preparations for medical purposes; in vitro diagnostic preparations for medical purposes; diagnostic reagents for medical purposes; clinical medical diagnostic reagents; reagents for medical use; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparationsa drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; drugs for medical purposes for treating infectious and metabolic diseases
Class 10
Medical diagnostic apparatus and instruments for monitoring infectious and metabolic diseases; diagnostic apparatus for medical purposesmolecular diagnostic apparatus; in vitro diagnostic devices for medical purposes for monitoring infections; medical instruments for infectious disease testing; medical diagnostic apparatus for testing for bacteria and virus; miniaturized medical sensors for use in gene analysis and diagnosis; medical apparatus and instruments other than for dental purposes for monitoring infectious and metabolic diseases; apparatus for carrying-out diagnostic tests for medical purposes for testing DNA and RNA samples; medical apparatus and instruments in the fields of clinical diagnosisfor diagnostic uses for infectious and metabolic diseases; diagnostic apparatus and instruments for medical purposes for diagnostic uses for infectious and metabolic diseases; medical instruments to measure blood pressurecardiac output and other physiological and cardiovascular parameters; medical apparatuspolymerase chain reaction equipment; fluid injectors for medical purposes; syringes for injection of medical substances
Class 35
promoting the goods and services of others by means of operating an on-line comprehensive shopping mall with links to the retail web sites of others; business intermediary services relating to matching of potential private investors with entrepreneurs in the field of mail order by telecommunications who need funding; wholesale store services featuring medical diagnostic test strips; retail store services featuring medical diagnostic test strips; wholesale store services featuring diagnostic test reagents for medical purposes; retail store services featuring diagnostic test reagents for medical purposes; wholesale store services featuring clinical diagnostic reagents; retail store services featuring clinical diagnostic reagents; wholesale store services featuring pharmaceuticals; retail store services featuring pharmaceuticals; wholesale store services featuring medical diagnostic apparatus and instruments; retail store services featuring medical diagnostic apparatus and instruments; wholesale store services featuring bacteria and virus testing apparatus; retail store services featuring bacteria and virus testing apparatus; wholesale store services featuring medical apparatus and instruments other than for dental purposes; retail store services featuring medical apparatus and instruments other than for dental purposes; wholesale store services featuring syringes for injection of medical substances; retail store services featuring syringes for injection of medical substances; wholesale store services featuring apparatus for medical purposes; retail store services featuring apparatus for medical purposes
Publications
History of USPTO decisions and trademark events.
25 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/01/2022
FIMP
FINAL DISPOSITION PROCESSED
02/28/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/14/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
09/14/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/29/2021
PUBO
PUBLISHED FOR OPPOSITION
06/29/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/09/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/26/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
05/26/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/26/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
05/26/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/26/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/18/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/18/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/18/2021
RFNT
REFUSAL PROCESSED BY IB
12/13/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/23/2020
RFRR
REFUSAL PROCESSED BY MPU
11/23/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/05/2020
CNRT
NON-FINAL ACTION WRITTEN
11/04/2020
DOCK
ASSIGNED TO EXAMINER
11/03/2020
MAFR
APPLICATION FILING RECEIPT MAILED
10/23/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/19/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/15/2020
Continuous trademark protection
Get notified about every new filing that threatens CELLSAFE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.